(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KALTREXIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

KALTREXIN

ST13

US500000090841105

Class

5

Filing

90841105

Registration

7249977

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

27

Latest update

12/19/2023

Trademark type

Word

Nice classes

5

Filing date

07/21/2021

Registration date

12/19/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/19/2023

Last transaction

12/19/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2023-05-00

First use in commerce

2023-05-00

Drawing code

4

Owner type

16

Owner location

Boca Raton, FL

Examiner

WU, KRISTEN

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Medix Health LLC

Representatives

Rebecca Liebowitz VENABLE LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Dietary and nutritional supplements

Publications

History of USPTO decisions and trademark events.

27 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/19/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/19/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

11/16/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

11/15/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

11/15/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/15/2023

IUAF

USE AMENDMENT FILED

11/02/2023

EISU

TEAS STATEMENT OF USE RECEIVED

11/02/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/27/2023

EX1G

SOU EXTENSION 1 GRANTED

04/25/2023

EXT1

SOU EXTENSION 1 FILED

04/25/2023

EEXT

SOU TEAS EXTENSION RECEIVED

04/25/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/15/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/20/2022

PUBO

PUBLISHED FOR OPPOSITION

09/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/31/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/11/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/11/2022

ALIE

ASSIGNED TO LIE

08/10/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/13/2022

GNRT

NON-FINAL ACTION E-MAILED

04/13/2022

CNRT

NON-FINAL ACTION WRITTEN

04/13/2022

DOCK

ASSIGNED TO EXAMINER

04/13/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/22/2021

NWAP

NEW APPLICATION ENTERED

07/24/2021

Continuous trademark protection

Get notified about every new filing that threatens KALTREXIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.